EDURANT 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
EDURANT 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
11736001
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jan 12, 2012
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number11736001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RILPIVIRINAActive
Quantity: 25 mg
Name: RILPIVIRINA
ATC CLASSIFICATION (3)
J05A
J05AG
J05AG05